Luye Pharma Acquires AstraZeneca’s Signature Products Seroquel and Seroquel XR

May 27, 2018 | By - | Filed in: Press Releases.

HONG KONG, May 27, 2018 /PRNewswire/ — Luye Pharma Group recently announced their acquisition of AstraZeneca’s core CNS products – Seroquel and Seroquel XR. As with previous acquisitions such as Lipusu, Xuezhikang, Beixi and Rivastigmine Transdermal Patch, the decision to acquire…

To post and circulate your own press release on FIR and the eTN Network  please click here 


Comments are closed here.